atopic eczema: clinical features and diagnosis focus 286 clinical pharmacist september 2010 vol 2...

3
CLINICAL FOCUS Vol 2 September 2010 Clinical Pharmacist 285 By Christine Clark, PhD, FRPharmS A topic eczema is an inflammatory skin condition that affects all age groups, but usually starts in childhood. It is the most common form of eczema, affecting up to 20% of children and 2–10% of adults in the UK. Moreover, there has been a steady increase in the prevalence of atopic eczema over the past 30 years. 1 There are many clinical variants of eczema (see Box 1, p286) but the common features are red, itchy, sore and inflamed skin. The terms “eczema” and “dermatitis” are now used interchangeably (see Box 2, p289). Atopic eczema can have a substantial negative impact on quality of life for both the sufferer and his or her family — an Australian study showed that caring for children with moderate-to-severe atopic eczema was more stressful than caring for children with type 1 diabetes. 2 Inability to sleep due to severe itching means that schoolwork and home life are disrupted and, for some people, eczema affecting the hands also interferes with their ability to work. Additionally, the erroneous belief that eczema is contagious can prompt negative reactions to the condition from other people. The epidermal barrier The skin has two main layers: the dermis and the epidermis. The dermis is 3–5mm thick and contains blood vessels, hair follicles and sweat glands. The epidermis is the surface layer which varies in thickness from about 0.06mm on the eyelids to 0.8mm on the palms and soles of the feet. The epidermis is composed of four layers of densely packed keratinocytes (skin cells). Keratinocytes are continually formed in the basal layer and gradually move upwards to the stratum corneum. As they move they change progressively from plump, nucleated cells to flattened, dead cells that are shed. This process takes about 28 days. Several factors contribute to the formation of the epidermal barrier. The uppermost layer of the epidermis (stratum corneum) can be visualised as a brick wall where the cells (now known as corneocytes) are the bricks. They are held together by mortar made up of intercellular lipids that are extruded from the maturing cells (see Figure 1, p286). Also contributing to cell compaction in the epidermis is a protein called filaggrin. Filaggrin is broken down to form smaller units (filaggrin monomers) that bind to keratin. Further breakdown of filaggrin releases amino acids that are constituents of natural moisturising factor (NMF). 3 NMF enhances the epidermal barrier by ensuring water is held in the cells — cells with a high water content swell and press tightly against each another, with no gaps. Finally, the cells are linked by protein bridges known as corneodesmosomes. Corneocytes are shed from the uppermost surface when the corneodesmosomes are cleaved by skin proteases. Thus, although cells are continuously shed from the upper surface of the stratum corneum, the deeper layers are held together firmly through the combined actions of barrier lipids, NMF and corneodesmosomes. This is Atopic eczema can have a substantial impact on a patient’s daily living. Assessment should focus on both physical and quality-of-life aspects of the disease to ensure optimal management Atopic eczema clinical features and diagnosis Christine Clark is a freelance journalist and chairman of the Skin Care Campaign, a UK organisation representing the interests of people with skin diseases. E: [email protected] SUMMARY Atopic eczema (or atopic dermatitis) is an inflammatory, itchy skin condition that follows a relapsing and remitting course. It usually starts in early childhood and is often caused by a genetic defect that leads to a breakdown of the skin barrier. Trigger factors, such as irritants and allergens, can precipitate flares of eczema or make the condition worse. Although atopic eczema is often not considered to be a serious medical condition, it can have a substantial impact on quality of life for patients and carers. Viki2win | Dreamstime.com Soap should be avoided by people with eczema

Upload: vanhanh

Post on 07-Jul-2018

232 views

Category:

Documents


0 download

TRANSCRIPT

CLINICAL FOCU

SVol 2 September 2010 Clinical Pharmacist 285

By Christine Clark, PhD, FRPharmS

Atopic eczema is an inflammatory skin condition thataffects all age groups, but usually starts in childhood.It is the most common form of eczema, affecting up

to 20% of children and 2–10% of adults in the UK.Moreover, there has been a steady increase in theprevalence of atopic eczema over the past 30 years.1

There are many clinical variants of eczema (see Box 1,p286) but the common features are red, itchy, sore andinflamed skin. The terms “eczema” and “dermatitis” arenow used interchangeably (see Box 2, p289).

Atopic eczema can have a substantial negative impacton quality of life for both the sufferer and his or herfamily — an Australian study showed that caring forchildren with moderate-to-severe atopic eczema was morestressful than caring for children with type 1 diabetes.2

Inability to sleep due to severe itching means thatschoolwork and home life are disrupted and, for somepeople, eczema affecting the hands also interferes withtheir ability to work. Additionally, the erroneous beliefthat eczema is contagious can prompt negative reactions tothe condition from other people.

The epidermal barrierThe skin has two main layers: the dermis and theepidermis.

The dermis is 3–5mm thick and contains blood vessels,hair follicles and sweat glands.

The epidermis is the surface layer which varies inthickness from about 0.06mm on the eyelids to 0.8mm onthe palms and soles of the feet. The epidermis is composedof four layers of densely packed keratinocytes (skin cells).Keratinocytes are continually formed in the basal layer andgradually move upwards to the stratum corneum. As theymove they change progressively from plump, nucleatedcells to flattened, dead cells that are shed. This processtakes about 28 days.

Several factors contribute to the formation of theepidermal barrier. The uppermost layer of the epidermis(stratum corneum) can be visualised as a brick wall wherethe cells (now known as corneocytes) are the bricks. They

are held together by mortar made up of intercellular lipidsthat are extruded from the maturing cells (see Figure 1,p286).

Also contributing to cell compaction in the epidermis isa protein called filaggrin. Filaggrin is broken down to formsmaller units (filaggrin monomers) that bind to keratin.Further breakdown of filaggrin releases amino acids thatare constituents of natural moisturising factor (NMF).3

NMF enhances the epidermal barrier by ensuring water isheld in the cells — cells with a high water content swelland press tightly against each another, with no gaps.

Finally, the cells are linked by protein bridges known ascorneodesmosomes. Corneocytes are shed from theuppermost surface when the corneodesmosomes arecleaved by skin proteases.

Thus, although cells are continuously shed from theupper surface of the stratum corneum, the deeper layersare held together firmly through the combined actions ofbarrier lipids, NMF and corneodesmosomes. This is

Atopic eczema can have a substantial impact on a patient’s daily living. Assessment should focus on both physical and quality-of-life aspects of the disease to ensure optimal management

Atopic eczemaclinical features and diagnosis

Christine Clark is a freelance journalist and chairmanof the Skin Care Campaign, a UK organisationrepresenting the interests of people with skin diseases. E: [email protected]

SUMMARYAtopic eczema (or atopic dermatitis) is an inflammatory, itchy skincondition that follows a relapsing and remitting course. It usually starts inearly childhood and is often caused by a genetic defect that leads to abreakdown of the skin barrier.

Trigger factors, such as irritants and allergens, can precipitate flares ofeczema or make the condition worse. Although atopic eczema is often notconsidered to be a serious medical condition, it can have a substantialimpact on quality of life for patients and carers.

Viki

2win

| Dr

eam

stim

e.co

m

Soap should be avoided by people with eczema

CP, Sept, CF1, p285-89_Layout 1 8/24/2010 1:14 PM Page 285

CLIN

ICAL

FOC

US

286 Clinical Pharmacist September 2010 Vol 2

known as the epidermal barrier and it serves to preventexcessive water loss from healthy skin and to prevent theentry of allergens and irritants.

PathophysiologyAtopic eczema appears to be caused by geneticallydetermined defects in the epidermal barrier of the skin,which increase the susceptibility of the skin to damagefrom environmental factors. Such damage allows the entryof allergens and irritants that trigger immune andinflammatory responses. Therefore, some experts havedescribed eczema as the result of a gene-environmentinteraction.

In atopic eczema, the intercellular lipids are not formednormally, which reduces the effectiveness of theepidermal barrier.4 There is increased water loss from thestratum corneum causing the corneocytes to shrink; cracksthen open up between the cells. The result is dry skin,which can neither retain water effectively nor prevent theincursion of irritants or allergens.

Two genetic variations have been identified recentlythat go some way towards explaining these changes. Thefirst is a genetic filaggrin deficiency which leads to apoorly formed stratum corneum that is prone to water loss.It is estimated that filaggrin gene defects are present in onein 10 Europeans.5

Another genetic defect leads to high levels of a skinprotease called stratum corneum chymotryptic enzyme —this is also associated with atopic eczema. Furthermore,raising the skin pH from 5.5 to 7.5, for example (as happenswhen washing with soap), results in a doubling of proteaseactivity.4

Similar changes can also be seen in normal skin whensome of the epidermal lipids are removed by repeated useof surfactants or solvents. The use of soap not onlyremoves natural oils from the skin, making it feel dry, italso increases shedding of skin cells.

People with atopic eczema are more sensitive to thedetrimental effects of soap than people without thecondition. The absence of visible eczema in a particulararea does not alter this — a lower threshold for irritationremains even if the skin appears “normal”.

Current thinking suggests that when irritants andallergens penetrate the weakened epidermal barrier theytrigger immune responses, including the release of pro-

inflammatory cytokines. The problems are furtherexacerbated by scratching, which relieves itchingtemporarily but further damages the skin and can itselftrigger further release of inflammatory mediators, therebyincreasing inflammation and itching and perpetuating thecycle (the “itch-scratch cycle”).

DiagnosisA diagnosis of atopic eczema is made with the presence ofan itchy rash plus three or more of the following:6

� Visible flexural dermatitis (or visible dermatitis onthe cheeks or outer aspects of the limbs in children)

� Personal history of flexural dermatitis (or dermatitison the cheeks in children under 10 years of age)

� Personal history of dry skin in the past 12 months� Personal history of asthma (or history of atopic

disease in a first-degree relative for children)� Onset of signs and symptoms under the age of two

years (this criterion should not be used in childrenunder four years of age)

Minor changes to the diagnostic criteria for childrenwere made in the 2007 National Institute for Health andClinical Excellence guidance for atopic eczema inchildren.7

Acute eczema can be accompanied by exudation andcrusting, while chronic eczema lesions are dry, lichenifiedand fissured.

Other dermatological conditions can be mistaken foreczema. Scabies can look like eczema and the severe itchingthat accompanies established scabies infestation adds to theconfusion. Scabies and head lice can also precipitate localflare of eczema. Psoriasis can sometimes look like eczema,but psoriasis plaques are usually found on extensor(outside) surfaces whereas eczema, in adults, morecommonly affects flexor (inside) surfaces. Fungal infectionsand rosacea can also mimic the appearance of eczema.

Box 1: Other types of eczema

TYPE OF ECZEMA DETAILS

Irritant contact Triggered by contact with irritant substances (eg,shampoo, detergents)

Allergic contact Triggered by contact with allergens (eg, chromate,nickel, perfumes, preservatives)

Seborrhoeic Typically affects scalp, eyebrows and ears, but canalso affect axillae. Characteristic greasy yellow scales.Associated with Pityrosporum spp overgrowth

Gravitational (varicose) Associated with oedematous legs. Skin is fragile andcan ulcerate if scratched

Asteatotic Occurs on the legs of elderly patients where the skin isvery dry. Appear as fine, red, superficial fissures

Pompholyx Presents with vesicles or large blisters on the palms,fingers or soles of the feet

Discoid Multiple coin-shaped, itchy lesions, typically found inmiddle-aged men. Thought to be stress-related.

Chronic hand Erythema, vesicles, papules, scaling, fissures, itchingand pain affecting the hands. Can be incapacitating

Figure 1: Representation of the brick-like structure of the epidermal barrier

Natural moisturising factorCorneocyte

Intercellular lipidsCorneodesmosome

CP, Sept, CF1, p285-89_Layout 1 8/24/2010 1:14 PM Page 286

CLINICAL FOCU

SVol 2 September 2010 Clinical Pharmacist 289

AssessmentExperts recommend that assessment of a patient witheczema should embrace both the physical aspects of thecondition and its impact on quality of life. The NICEguideline for the management of atopic eczema inchildren7 outlines a severity grading scheme, incorporatingboth physical and quality-of-life assessments (see Box 3).

Clinicians should always conduct both physical andquality-of-life assessments because even mild eczema canaffect a patient’s well-being.

Course of diseaseAtopic eczema commonly starts in early childhood, but itcan also start later in life. Like other inflammatory skindiseases it runs a relapsing and remitting course with theseverity often varying from day to day. The “Internationalstudy of life with atopic eczema” (ISOLATE)8 showed that,on average, patients experienced nine flares per year, eachlasting for 15 days. Overall, patients spent an average of136 days per year experiencing flares.

ComplicationsA common complication of atopic eczema is bacterialinfection with Staphylococcus aureus, leading to impetigo.Eczematous skin is almost always colonised with S aureusbut treatment is only required when there is evidence ofinfection (eg, worsening inflammation, weeping, pustules,crusting, eczema failing to respond to treatment, rapidlyworsening eczema or, in severe cases, fever and malaise).

People with eczema are more susceptible to infectionwith viruses, such as those causing warts and molluscumcontagiosum.

Infants and young children with eczema can developwidespread lesions if infected with Herpes simplex (seeFigure 2). This condition, known as eczema herpeticum,requires urgent referral for medical attention because itcan be life-threatening. It is associated with:

� Areas of rapidly worsening, painful eczema� Possible fever, lethargy or distress� Clustered blisters that look like early-stage cold

sores� Uniform, punched-out erosions (usually 1–3mm

diameter) which may coalesce

Parents should be warned of the dangers of contact withanyone who has H simplex or cold sores.

The atopic marchAtopic eczema often develops as part of a wider pattern ofatopic conditions — this is known as the “atopic march”.Gastrointestinal symptoms (commonly due to an allergyto milk and eggs) occur in the first few months of life. Thisis followed by atopic eczema, often starting within the firstthree months. Later during childhood, asthma developsand then allergic rhinitis. The factors responsible for theatopic march are not fully understood but it is thought thatthe defective skin barrier seen in atopic eczema could playa key role.9

References 1 National Institute for Health and Clinical Excellence. Clinical Knowledge

Summaries: atopic eczema. www.cks.nhs.uk/eczema_atopic#-323502(accessed 13 August 2010).

2 Su JC, Kemp AS, Varigos GA, et al. Atopic eczema: its impact on thefamily and financial cost. Archives of Disease in Childhood1997;76:159–62.

3 Sandilands A, Sutherland C, Irvine AD, et al. Filaggrin in the frontline:role in skin barrier function and disease. Journal of Cell Science2009;122:1285–94.

4 Cork MJ. The importance of skin barrier function. Journal ofDermatological Treatment 1997;8:S7–13.

5 Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a majorpredisposing factor for atopic dermatitis. Nature Genetics 2006;38:441–6.

6 Williams HC, Burney PG, Hay RJ, et al. The UK Working Party’sDiagnostic Criteria for Atopic Dermatitis. British Journal of Dermatology1994;131:383–96.

7 National Institute for Health and Clinical Excellence. Atopic eczema inchildren. December 2007. www.nice.org.uk/cg57 (accessed 13 June 2010).

8 Zuberbier T, Orlow SJ, Paller AS, et al. Patient perspectives on themanagement of atopic dermatitis. Journal of Allergy and ClinicalImmunology 2006;118:226–32.

9 Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopicdermatitis. Journal of Clinical Investigation 2004;113:651–7.

Box 3: Assessment of atopic eczema4

GRADE PHYSICAL ASSESSMENT IMPACT ON QUALITY OF LIFE

Clear/none Normal skin; no evidence ofatopic eczema

No impact

Mild Areas of dry skin; infrequentitching (with or without smallareas of redness)

Little impact on everydayactivities, sleep and social well-being

Moderate Areas of dry skin; frequentitching; redness (with or withoutexcoriation and localised skinthickening)

Moderate impact on everydayactivities and psychosocial well-being; frequently disturbed sleep

Severe Widespread areas of dry skin;incessant itching; redness (withor without excoriation, extensiveskin thickening, bleeding,oozing, cracking and alteredpigmentation)

Severe limitation of everydayactivities and psychosocialfunctioning; nightly loss of sleep

Box 2: Key points about atopic eczema

� The terms eczema and dermatitis are interchangeable� Atopic eczema is the most common form of eczema� The common clinical feature is red, itchy, inflamed skin� Eczema can have a significant impact on quality of life� The severity of eczema often varies from day to day� Acute eczema can be accompanied by exudation and crusting, while

chronic eczema lesions are dry, lichenified and fissured

Figure 2: Eczema herpeticum affecting wrists and hands

St B

arth

olom

ew’s

Hosp

ital |

SPL

CP, Sept, CF1, p285-89_Layout 1 8/24/2010 1:14 PM Page 289